Published in J Clin Invest on December 01, 1970
Assay of total plasma apolipoprotein B concentration in human subjects. J Clin Invest (1974) 1.46
Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes. J Clin Invest (1976) 1.07
Plasma lipids and lipoproteins in liver disease. Gut (1978) 1.04
The hypercholesterolaemia of obstructive jaundice. Gut (1975) 0.99
Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest (1976) 0.96
Secretion of lipoprotein-X by perfused livers of rats with cholestasis. Proc Natl Acad Sci U S A (1978) 0.90
Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman. World J Gastroenterol (2004) 0.80
Liquid crystalline lipid in the plasma of humans with biliary obstruction. J Clin Invest (1972) 0.80
Studies on cholesterol ester formation and hydrolysis in liver disease: a selective review. Yale J Biol Med (1979) 0.75
Liver serine palmitoyltransferase activity deficiency in early life impairs adherens junctions and promotes tumorigenesis. Hepatology (2016) 0.75
Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis. Clin Lipidol (2015) 0.75
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96
Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. Biochem J (1955) 35.79
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest (1955) 31.08
Starch gel electrophoresis in a discontinous system of buffers. Nature (1957) 19.23
[Immunoelectrophoretic method for the analysis of mixtures of antigenic substances]. Biochim Biophys Acta (1955) 17.69
The oxidation of ribonuclease with performic acid. J Biol Chem (1956) 16.39
Separation of dansyl-amino acids by polyamide layer chromatography. Biochim Biophys Acta (1967) 12.65
Study of the dansylation reaction of amino acids, peptides and proteins. Eur J Biochem (1969) 4.27
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 2.86
Protein-lipid relationships in human plasma: in biliary cirrhosis, obstructive jaundice, and acute hepatitis. J Clin Invest (1955) 2.84
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Isolation and characterization of polypeptides of human serum lipoproteins. Biochemistry (1969) 1.87
ACCELERATED AUTOMATIC CHROMATOGRAPHIC ANALYSIS OF AMINO ACIDS ON A SPHERICAL RESIN. Anal Chem (1965) 1.84
Separation and characterization of the protein moiety of human alpha1-lipoprotein. Arch Biochem Biophys (1958) 1.69
Lipoproteins in primary biliary cirrhosis. J Clin Invest (1956) 1.62
The nature of pre beta (very low density) lipoproteins. J Clin Invest (1966) 1.48
Lipid composition of human serum lipoproteins. Biochem J (1967) 1.45
STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM. Biochemistry (1965) 1.42
Solubilization and properties of the apoproteins of the very low- and low-density lipoproteins of human serum. Biochemistry (1966) 1.30
Further separation of the apoproteins of the human plasma very low density lipoproteins. Biochim Biophys Acta (1970) 1.28
Studies on the antigenicity of beta- and alpha-lipoproteins of human serum. J Exp Med (1958) 1.25
Immunologic studies of human high density lipoproteins. J Exp Med (1957) 1.23
Some physical and chemical studies on two polypeptide components of high-density lipoproteins of human serum. Biochemistry (1968) 1.20
Studies on human serum beta-1-lipoprotein. I. Amino acid composition. J Biol Chem (1966) 1.19
Effects of ultracentrifugation on the human serum high-density (1.063 less than p less than 1.21 g/ml) lipoprotein. Biochemistry (1966) 1.18
Heterogeneity in protein subunits of human serum high-density lipoproteins. Biochemistry (1968) 1.18
Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction. J Clin Invest (1967) 1.18
The N-terminal sequence of serum albumins; observations on the thiohydantoin method. J Biol Chem (1954) 1.13
Ultracentrifugal characterization of the lipoprotein spectrum in obstructive jaundice: studies of serum lipid relationships in intra-and extrahepatic biliary obstruction. J Clin Invest (1957) 1.13
Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry (1970) 1.12
AN UNUSUAL SERUM LIPOPROTEIN-GLOBULIN COMPLEX IN A PATIENT WITH HYPERLIPEMIA. Am J Med (1965) 1.11
STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: PHYSICAL-CHEMICAL CHARACTERIZATION OF PHOSPHOLIPID-PROTEIN RESIDUES OBTAINED FROM VERY-LOW-DENSITY HUMAN SERUM LIPOPROTEINS. Biochim Biophys Acta (1964) 1.04
Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry (1966) 1.02
Observations on the protein components of human plasma high- and low-density lipoproteins. Biochemistry (1968) 0.94
Association of cold-precipitability with beta-lipoprotein and cryoglobulin. Am J Med (1966) 0.92
Some physical and chemical studies on the protein moiety of a high-density (1.126-1.195 g-ml) lipoprotein fraction of human serum. Biochemistry (1967) 0.92
Amino acid composition of the proteins from chylomicrons and human serum lipoproteins. J Lipid Res (1967) 0.89
Isolation and characterization of human chyle chylomicrons and lipoproteins. Ann N Y Acad Sci (1968) 0.88
A demonstration of the coprecipitation of beta-lipoproteins with specific precipitates of chicken antibodies and human serum albumin. J Immunol (1968) 0.87
[A new biological test for cholostasis]. Presse Med (1965) 0.85
[Myeloma, hyperlipemia and xanthomatosis]. Nouv Rev Fr Hematol (1965) 0.83
[Separation by ultracentrifugation of the alpha-lipoproteins of normal human serum]. Bull Soc Chim Biol (Paris) (1963) 0.83
Identification of the protein moiety of an abnormal human plasma low-density lipoprotein in obstructive jaundice. FEBS Lett (1969) 0.81
[Isolation and study of abnormal serum lipoproteins during retention jaundice after flocculation by polyvinylpyrrolidone]. Rev Fr Etud Clin Biol (1968) 0.80
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Low status control, high effort at work and ischemic heart disease: prospective evidence from blue-collar men. Soc Sci Med (1990) 2.63
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation (1993) 2.04
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79
Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther (2010) 1.76
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta (1972) 1.73
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation (1997) 1.70
Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67
Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. Clin Chim Acta (1991) 1.47
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43
Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur J Clin Invest (1998) 1.42
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
Aortic valve thickening associated with power training: is it pressure overload? Am J Cardiol (1998) 1.40
Degradative effect of phenol on endotoxin and lipopolysaccharide preparations from Serratia marcescens. J Bacteriol (1974) 1.39
Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle-aged men. J Intern Med (1997) 1.38
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38
[Is the alcoholic really sober, does the applicant drink, can the pilot still fly? CDT test often fails in reliability!]. MMW Fortschr Med (2000) 1.37
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
A simple specific method for precipitation of low density lipoproteins. J Lipid Res (1983) 1.33
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33
Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease. Ann N Y Acad Sci (1968) 1.31
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res (2000) 1.25
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Apoliproproteins and lipoproteins. Atherosclerosis (1971) 1.17
Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med (2001) 1.17
Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res (1989) 1.17
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant (1994) 1.17
Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem (1976) 1.15
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation (1994) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett (1973) 1.13
Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer (2001) 1.13
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest (1994) 1.12
Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry (1970) 1.12
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08. Biochemistry (1973) 1.11
Anabolic steroid-induced hepatotoxicity: is it overstated? Clin J Sport Med (1999) 1.10
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09
Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. Br J Cancer (2002) 1.08
Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest (1990) 1.08
Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-beta1. Histochem Cell Biol (2004) 1.07
Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta (1976) 1.06
Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry (1972) 1.05
Structure and functional properties of lipoprotein lipase. Biochim Biophys Acta (1992) 1.05
The differential diagnosis of neonatal hepatitis and biliary atresia. J Pediatr Surg (1974) 1.04
Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalence Study (GRIPS). Klin Wochenschr (1988) 1.04
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res (1983) 1.03
Studies on the characterization of lipopolysaccharides from two strains of Serratia marcescens. Ann N Y Acad Sci (1966) 1.03
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Nephron (1991) 1.02
Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry (1966) 1.02
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects. Clin Cardiol (1999) 1.02
Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta (1980) 1.02
Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis (1989) 1.01
Hypertriglyceridaemia secondary to liver disease. Eur J Clin Invest (1974) 1.01
Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett (1997) 1.01
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest (1989) 1.00
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry (1978) 1.00
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens Bizio. Biochemistry (1973) 0.99
Circulating nucleosomes in serum. Ann N Y Acad Sci (2001) 0.99
Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta (1991) 0.98
Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem (1978) 0.98
GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes (1998) 0.98
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Biochim Biophys Acta (1987) 0.98
Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. Biochemistry (1976) 0.97
Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem (1991) 0.97
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int (1988) 0.97
Growth hormone in the regulation of hyperlipidemia. Metabolism (1982) 0.96
Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI. Hum Genet (1982) 0.96
Techniques for studying anabolism and catabolism in humans. J Am Med Womens Assoc (1968) 0.96
Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. J Lipid Res (1990) 0.96
Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest (1976) 0.96
Purification and molecular cloning of human apolipoprotein F. Biochem Biophys Res Commun (1994) 0.95
Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate-accentuated lipemia. J Lab Clin Med (1965) 0.95
Apoptosis in serum of patients with solid tumours. Anticancer Res (1999) 0.94
Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim Biophys Acta (1996) 0.94
Intra-ocular pressure changes during maximal isometric contraction: does this reflect intra-cranial pressure or retinal venous pressure? Neurol Res (1999) 0.94
Epidemiological evidence for work load as a risk factor for osteoarthritis of the hip: a systematic review. PLoS One (2012) 0.93
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy. J Acquir Immune Defic Syndr (2001) 0.93
Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta (1977) 0.93